Hematopoietic stem cell transplantation for severe sickle cell disease;Greffe de cellules souches hématopoïétiques dans la drépanocytose homozygote sévère

Revue Medicale de Bruxelles

Volumn 26, Issue SPEC. ISS., 2005, Pages

  Klein, A ^a   Brachet, C ^a   Azzi, N ^a   Ferster, A ^a  

^a HUDERF   (Belgium)

Author keywords

Hematopoietic; Sickle cell disease; Transplantation

Indexed keywords

ADULT; BLOOD DONOR; BONE MARROW CELL; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; QUALITY OF LIFE; REVIEW; SIBLING; SICKLE CELL ANEMIA; UMBILICAL CORD BLOOD;

ANEMIA, SICKLE CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 30544449701     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Platt OS, Brambilla DJ, Rosse WF et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994; 330: 1639-1644
2. Steinberg MH, Barton F, Castro O et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003; 289: 1645-51
3. Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billings FT 3rd. Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med. 1984; 311: 780-3.
4. Vermylen C, Fernandez Robles E, Ninane J, Cornu G. Bone marrow transplantation in five children with sickle cell anaemia. Lancet. 1988, 8600, 1427-1428
5. Walters MC, Patience M, Leisenring W et al. Bone marrow transplantation for sickle cell disease. N Engl J Med. 1996; 335: 369-76
6. Miller ST, Sleeper LA, Pegelow CH et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000; 342: 83-89
7. Brachet C, Azzi N, Demulder A et al. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome. Bone Marrow Transplant. 2004; 33: 799-803
8. lannone R, Casella JF, Fuchs EJ et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant. 2003; 9: 519-28
9. Adamkiewicz TV, Mehta PS, Boyer MW et al. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Transplant. 2004; 34: 405-11.
10. Adler BK, Salzman DE, Carabasi MH, Vaughan WP, Reddy VV, Prchal JT. Fatal sickle cell crisis after granulocyte colony-stimulating factor administratio. Blood. 2001; 97: 3313-3314
11. Locatelli F, Rocha V, Reed W et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003; 101: 2137-43
12. Walters MC, Storb R, Patience M et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood. 2000; 95: 1918-24
13. Vermylen C, Cornu G, Ferster A et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant. 1998; 22: 1-6.
14. Bernaudin F., Vernant JP, Vilmer E. et al. Results of myeloablative stem cell transplant for severe sickle cell disease. Blood. 2002; 100 (11): 5a
15. Ferster A, Bujan W, Corazza F et al. Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood. 199p3; 81: 1102-5.
16. Vermylen C., Cornu G., Ferster A. et al. Sickle cell disease and haematopoietic stem cell transplantation in Belgium. Bone Marrow Transplant. 1997; 19: 99-101